GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeward Ltd (NAS:LFWD) » Definitions » Gross Margin %

LFWD (Lifeward) Gross Margin % : 24.44% (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Lifeward Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Lifeward's Gross Profit for the three months ended in Dec. 2024 was $1.84 Mil. Lifeward's Revenue for the three months ended in Dec. 2024 was $7.55 Mil. Therefore, Lifeward's Gross Margin % for the quarter that ended in Dec. 2024 was 24.44%.

Warning Sign:

Lifeward Ltd gross margin has been in long-term decline. The average rate of decline per year is -11.9%.


The historical rank and industry rank for Lifeward's Gross Margin % or its related term are showing as below:

LFWD' s Gross Margin % Range Over the Past 10 Years
Min: 5.71   Med: 37.29   Max: 55.94
Current: 32.02


During the past 13 years, the highest Gross Margin % of Lifeward was 55.94%. The lowest was 5.71%. And the median was 37.29%.

LFWD's Gross Margin % is ranked worse than
78.18% of 802 companies
in the Medical Devices & Instruments industry
Industry Median: 53.04 vs LFWD: 32.02

Lifeward had a gross margin of 24.44% for the quarter that ended in Dec. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Lifeward was -11.90% per year.


Lifeward Gross Margin % Historical Data

The historical data trend for Lifeward's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeward Gross Margin % Chart

Lifeward Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.83 48.66 34.57 32.14 32.01

Lifeward Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.49 26.41 41.11 36.23 24.44

Competitive Comparison of Lifeward's Gross Margin %

For the Medical Devices subindustry, Lifeward's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifeward's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeward's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Lifeward's Gross Margin % falls into.


;
;

Lifeward Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Lifeward's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=8.2 / 25.663
=(Revenue - Cost of Goods Sold) / Revenue
=(25.663 - 17.447) / 25.663
=32.01 %

Lifeward's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=1.8 / 7.545
=(Revenue - Cost of Goods Sold) / Revenue
=(7.545 - 5.701) / 7.545
=24.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Lifeward  (NAS:LFWD) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lifeward had a gross margin of 24.44% for the quarter that ended in Dec. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Lifeward Gross Margin % Related Terms

Thank you for viewing the detailed overview of Lifeward's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeward Business Description

Traded in Other Exchanges
N/A
Address
200 Donald Lynch Boulevard, Marlborough, MA, USA, 01752
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
Executives
Turk Joseph E Jr director NXSTAGE MEDICAL INC, 439 SOUTH UNION STREET 5TH FLOOR, LAWRENCE MA 01843
Randel Richner director C/O REWALK ROBOTICS, LTD., 3 HATNUFA ST. 6TH FL. P.O. BOX 161, YOKNEAM L3 2069203
Lawrence J Jasinski director, officer: Chief Executive Officer SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
Jeannine Lynch officer: VP of Market Access & Strategy C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., P.O. BOX 161, YOKNEAM ILIT L3 20692203
Michael A Lawless officer: Chief Financial Officer C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Lind Global Fund Ii Lp 10 percent owner 444 MADISON AVENUE, 41ST FLOOR, NEW YORK NY 10022
Lind Global Macro Fund Lp 10 percent owner 444 MADISON AVE, FLOOR 41, NEW YORK NY 10022
Jeff Dykan director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Aryeh Dan director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Charles Remsberg officer: Chief Sales Officer C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Poduska John William Sr director 295 MEADOWBROOK RD, WESTON MA 02493
Yasushi Ichiki director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Yohanan Engelhardt director 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Hadar Levy director C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Wayne Weisman director 490 LAPP ROAD, MALVERN PA 19355